Cite
The evaluation of pretreatment neutrophil-lymphocyte ratio and derived neutrophil-lymphocyte ratio in patients with laryngeal neoplasms
MLA
Ece Onur, et al. “The Evaluation of Pretreatment Neutrophil-Lymphocyte Ratio and Derived Neutrophil-Lymphocyte Ratio in Patients with Laryngeal Neoplasms.” Brazilian Journal of Otorhinolaryngology, vol. 85, no. 5, Feb. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f36116f4263d6270df1fee15919980dd&authtype=sso&custid=ns315887.
APA
Ece Onur, Beyhan Cengiz Özyurt, Gizem Karaca Cikrikci, Nevin Sahin, Uzdan Uz, Görkem Eskiizmir, Arzu Oran, & Onur Celik. (2018). The evaluation of pretreatment neutrophil-lymphocyte ratio and derived neutrophil-lymphocyte ratio in patients with laryngeal neoplasms. Brazilian Journal of Otorhinolaryngology, 85(5).
Chicago
Ece Onur, Beyhan Cengiz Özyurt, Gizem Karaca Cikrikci, Nevin Sahin, Uzdan Uz, Görkem Eskiizmir, Arzu Oran, and Onur Celik. 2018. “The Evaluation of Pretreatment Neutrophil-Lymphocyte Ratio and Derived Neutrophil-Lymphocyte Ratio in Patients with Laryngeal Neoplasms.” Brazilian Journal of Otorhinolaryngology 85 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f36116f4263d6270df1fee15919980dd&authtype=sso&custid=ns315887.